INNOVATION

Pipeline

OnQuality Pharmaceuticals is pioneering the field of targeted supportive cancer care. Our lead compound is an oncodermatology hand and foot ointment called OQL011, which is for the treatment of Hand-Foot Skin Reaction. It is being studied in a phase 2 clinical trial that is currently enrolling. We also have two promising assets that are currently in the pre-clinical stage and will enter clinical trials in the near future.  Additionally, we have two promising assets that are in the early discovery stage targeting oncogastroenterology conditions.

​